Literature DB >> 2873607

Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.

A Vaccheri, R Dall'Olio, O Gandolfi, N Montanaro.   

Abstract

A critical dose of apomorphine (300 micrograms/kg SC) given immediately before placing rats into a novel environment produced a diphasic motility response (initial sedation followed by enhanced locomotion). Various neuroleptics having different clinical and/or pharmacological profiles were studied by using such a model. (-)-Sulpiride and sultopride preferentially antagonized apomorphine inhibition; haloperidol and tiapride antagonized both phases of apomorphine response at similar doses; chlorpromazine, fluphenazine, thioridazine, metoclopramide and SCH 23390 preferentially antagonized apomorphine stimulation. The results are discussed in terms of the dopamine receptor subtypes involved in the two phases of apomorphine effect. Apomorphine stimulation can be antagonized by D-1 as well as D-2 receptor blockade. A higher affinity for D-2 receptors seems a necessary requisite for the antagonism of apomorphine inhibition; moreover, the ability of neuroleptics to antagonize apomorphine inhibition seems to depend on the ratio of their presynaptic versus postsynaptic D-2 activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873607     DOI: 10.1007/bf00174356

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.

Authors:  N E Andén; U Strömbom; T H Svensson
Journal:  Psychopharmacologia       Date:  1973

3.  Effect of apomorphine on motility in rats.

Authors:  J Maj; M Grabowska; L Gajda
Journal:  Eur J Pharmacol       Date:  1972-02       Impact factor: 4.432

4.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.

Authors:  S Boyce; E Kelly; A Davis; S Fleminger; P Jenner; C D Marsden
Journal:  Biochem Pharmacol       Date:  1985-05-15       Impact factor: 5.858

6.  Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.

Authors:  A V Christensen; J Arnt; J Hyttel; J J Larsen; O Svendsen
Journal:  Life Sci       Date:  1984-04-16       Impact factor: 5.037

7.  Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat.

Authors:  S Fleminger; H van de Waterbeemd; N M Rupniak; C Reavill; B Testa; P Jenner; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1983-06       Impact factor: 3.765

8.  Time course of rat motility response to apomorphine: a simple model for studying preferential blockade of brain dopamine receptors mediating sedation.

Authors:  N Montanaro; A Vaccheri; R Dall'Olio; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist.

Authors:  E Meller; S Kuga; A J Friedhoff; M Goldstein
Journal:  Life Sci       Date:  1985-05-13       Impact factor: 5.037

10.  Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy.

Authors:  A Robertson; C MacDonald
Journal:  Eur J Pharmacol       Date:  1985-02-12       Impact factor: 4.432

View more
  6 in total

1.  Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.

Authors:  R Dall'Olio; O Gandolfi; P Roncada; A Vaccheri; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Behavioral differentiation between pharmacokinetic and pharmacodynamic components of the interaction of antidepressants or neuroleptics with methamphetamine.

Authors:  R Dall'Olio; A Vaccheri; O Gandolfi; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.

Authors:  E S Prosser; R Pruthi; J G Csernansky
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity.

Authors:  A Plaznik; R Stefanski; W Kostowski
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Dopamine D-2 antagonists reverse apomorphine-induced decreased water intake in the rat: prediction of antipsychotic drugs with few extrapyramidal side-effects?

Authors:  T Ljungberg
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

6.  Divergent effect of the selective D3 receptor agonist pd-128,907 on locomotor activity in Roman high- and low-avoidance rats: relationship to NGFI-A gene expression in the Calleja islands.

Authors:  Marc Guitart-Masip; Björn Johansson; Albert Fernández-Teruel; Adolf Tobeña; Lydia Giménez-Llort
Journal:  Psychopharmacology (Berl)       Date:  2007-10-19       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.